Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis

Abstract

Our studies suggest that the increased levels of CFDNA in sepsis impair fibrinolysis by inhibiting plasmin-mediated fibrin degradation, thereby identifying CFDNA as a potential therapeutic target for sepsis treatment.